Skip to content

AYURVEDIC MANAGEMENT OF SHORT SIGHT

A CLINICO-COMPARATIVE STUDY ON EFFICACY OF NASYAM AND TARPANA WITH MAHATRIPHALADI GHRITA IN PRATHAMA PATALAGATA TIMIR W.S.R. TO MYOPIA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018035
Enrollment
60
Registered
2019-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: EFFECT OF MAHATRIPHALADI GHRITA TARPANA IN MYOPIA: PATIENTS WILL BE GIVEN TARPANA WITH MAHATRIPHALADI GHRITA FOR 7 DAYS Control Intervention1: EFFECT OF NASYAM WITH MAHATRIPHALADI GHRIT

Sponsors

PATANJALI AYURVED COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with classical symptoms of timir/myopiA 2. Patients who are fit for nasya karma. 3. Patients who are fit for tarpana karma. 4. Patients with less than 6 D.

Exclusion criteria

Exclusion criteria: 1.Patients less than 8 yrs of age and above 35 years of age. 2.Patients suffering from any systemic diseases and receiving medicine. 3.Patients who are contraindicated for nasya and tarpana karma. 4.Patients with more than 6 D.

Design outcomes

Primary

MeasureTime frame
A). SUBJECTIVE :- 1) Headache 2) Watering of eyes 3) Blurred Vision 4) Pain in eyes B). OBJECTIVE :- 1) Visual Acuity 2) Auto refraction examination for refractive errors. Timepoint: Just Before intervention of nasyam and tarpan in myopia patients

Secondary

MeasureTime frame
A). SUBJECTIVE :- 1) Headache 2) Watering of eyes 3) Blurred Vision 4) Pain in eyes B). OBJECTIVE :- 1) Visual Acuity 2) Auto refraction examination for refractive errors.Timepoint: Immediately After intervention of nasyam and tarpan in myopia

Countries

India

Contacts

Public ContactDR PREETI PAHWA

PATANJALI BHARTIYA AYURVIGYAN EVUM ANUSANDHAN SANSTHAN

drpreeti25@gmail.com9953117417

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026